Live from the NIH registry
Studies recruiting near Nampa right now
Top 25 of 255 recruiting studies, sorted by proximity — each links to its official registry page
A Long-Term Follow-Up Study of Participants Exposed to REACT
Diabetic Kidney Disease, Chronic Kidney Diseases
N/A
Observational 80 participants sought
Boise Kidney & Hypertension Institute — Meridian, Idaho (8.8 mi)
· Sponsor: Prokidney
Stress Management for College Students
Distress, Emotional
N/A
Interventional 500 participants sought
Boise State University — Boise, Idaho (18.1 mi)
· Sponsor: Boise State University
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 180 participants sought
Ada West Research — Meridian, Idaho (8.8 mi)
· Sponsor: Organon and Co
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Boise, Idaho (18.1 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Treasure Valley Medical Research — Boise, Idaho (18.1 mi)
· Sponsor: Incyte Corporation
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy
TBI Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder
Phase 2
Interventional 54 participants sought
Summit Hyperbarics and Wellness — Boise, Idaho (18.1 mi)
· Sponsor: Summit Hyperbarics and Wellness
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12156 — Boise, Idaho (18.1 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
CARE Institute-Boise Kidney — Boise, Idaho (18.1 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Brain Metastases
Phase 3
Interventional 206 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (18.1 mi)
· Sponsor: Canadian Cancer Trials Group
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Atrial Fibrillation (AF), Persistant Atrial Fibrillation
N/A
Interventional 699 participants sought
St. Luke's Boise Medical Center — Boise, Idaho (18.1 mi)
· Sponsor: Boston Scientific Corporation
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Saint Luke's Cancer Institute - Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: NRG Oncology
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Boise VA Medical Center — Boise, Idaho (18.1 mi)
· Sponsor: Ferring Pharmaceuticals
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Growth Hormone Deficiency
N/A
Observational 900 participants sought
Ascendis Investigational Site — Boise, Idaho (18.1 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (18.1 mi)
· Sponsor: Children's Oncology Group
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (18.1 mi)
· Sponsor: Children's Oncology Group
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Wake Forest University Health Sciences
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
B-Cell Non-Hodgkins Lymphoma
Phase 2
Interventional 100 participants sought
St Luke?s Cancer Institute — Boise, Idaho (18.1 mi)
· Sponsor: Hoffmann-La Roche
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
Phase 2
Interventional 540 participants sought
Research Site — Boise, Idaho (18.1 mi)
· Sponsor: AstraZeneca
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Paradigm Clinical Research - Boise, ID — Boise, Idaho (18.1 mi)
· Sponsor: Sparrow Pharmaceuticals